Vitrolife AB (publ)
VTRLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $19 | $24 | $28 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $2 | $2 | $2 |
| Enterprise Value | $2 | $20 | $25 | $29 |
| Revenue | $0 | $1 | $1 | $1 |
| % Growth | -89.9% | 3.4% | -12.2% | – |
| Gross Profit | $0 | $1 | $0 | $1 |
| % Margin | 51% | 58% | 57.4% | 61.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 30.5% | 15.7% | 17.8% | 28.3% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 12.2% | 11.5% | 11.9% | 14.5% |
| EPS Diluted | 0.079 | 0.74 | 0.74 | 1.02 |
| % Growth | -89.3% | 0% | -27.5% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |